Q-omics provides the consensus-scored RNU6-269P profile across patient tissues and cancer cell-line models. RNU6-269P expression is associated with patient survival in 4 of 34 cancer types, with the highest sampling consensus in BLCA. Additionally, RNU6-269P RNA expression shows 8,787 significant gene co-expression associations, with the highest sampling consensus in TGCT. Together, these results highlight BLCA, and TGCT as cancer lineages where RNU6-269P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.